Xujun He

2.2k total citations
60 papers, 1.3k citations indexed

About

Xujun He is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xujun He has authored 60 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 17 papers in Cancer Research and 15 papers in Oncology. Recurrent topics in Xujun He's work include Cancer-related molecular mechanisms research (7 papers), Circular RNAs in diseases (7 papers) and MicroRNA in disease regulation (6 papers). Xujun He is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), Circular RNAs in diseases (7 papers) and MicroRNA in disease regulation (6 papers). Xujun He collaborates with scholars based in China, United States and Australia. Xujun He's co-authors include Hou‐Quan Tao, Hui‐Ju Wang, Yingjie Xia, Zai‐yuan Ye, Zhong‐Sheng Zhao, Yingyu Ma, Xiaoting Jiang, Ying‐Yu Ma, Ji Xu and Yuanyu Wang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and European Journal of Cancer.

In The Last Decade

Xujun He

59 papers receiving 1.3k citations

Peers

Xujun He

ONCOL

IMMUN

PRM

Xiaobin Cui China

Xiaobo Guo China

Lin Shi China

Xiaojing Cheng China

Yan Jia China

Jenn-Ren Hsiao Taiwan

Xuehui Hong China

Xinying Wang China

Ling Huang China

Michaël Perrais France

Xiaobin Cui China

Xujun He

908 ×1.1

518 ×1.0

273 ×1.1

ONCOL

108 ×0.6

IMMUN

219 ×1.2

PRM

Citations per year, relative to Xujun He Xujun He (= 1×) peers Xiaobin Cui

Countries citing papers authored by Xujun He

Since Specialization

Citations

This map shows the geographic impact of Xujun He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xujun He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xujun He more than expected).

Fields of papers citing papers by Xujun He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xujun He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xujun He. The network helps show where Xujun He may publish in the future.

Co-authorship network of co-authors of Xujun He

This figure shows the co-authorship network connecting the top 25 collaborators of Xujun He. A scholar is included among the top collaborators of Xujun He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xujun He. Xujun He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shen, Yan, Ping Chen, & Xujun He. (2024). HTA34 Cost-Effectiveness Analysis of Icosapent Ethyl (IPE) for the Reduction of the Severe Hypertriglyceridemia (HTG) in China. Value in Health. 27(6). S250–S251. 1 indexed citations

Wu, Xiangli, Yuqing Tian, Xujun He, et al.. (2024). Novel MEI1 mutations cause chromosomal and DNA methylation abnormalities leading to embryonic arrest and implantation failure. Molecular Genetics and Genomics. 299(1). 18–18. 3 indexed citations

Liu, Yao, et al.. (2023). Extended‐spectrum β‐lactamase‐producing Enterobacteriaceae from ready‐to‐eat foods: Genetic diversity and antibiotic susceptibility. Food Science & Nutrition. 11(9). 5565–5572. 4 indexed citations

Liu, Zhuo, Jie Ma, Dechuan Li, et al.. (2020). <p>Integrative Analysis of the IQ Motif-Containing GTPase-Activating Protein Family Indicates That the IQGAP3-PIK3C2B Axis Promotes Invasion in Colon Cancer</p>. OncoTargets and Therapy. Volume 13. 8299–8311. 12 indexed citations

Niu, Nan, et al.. (2020). IL35 predicts prognosis in gastric cancer and is associated with angiogenesis by altering TIMP1, PAI1 and IGFBP1. FEBS Open Bio. 10(12). 2687–2701. 11 indexed citations

Xie, Tengfei, et al.. (2019). Antimicrobial resistance and genetic diversity of Salmonella enterica from eggs. Food Science & Nutrition. 7(9). 2847–2853. 16 indexed citations

Lei, Kefeng, et al.. (2019). Breast cancer prognosis is better in patients who develop subsequent metachronous thyroid cancer. PLoS ONE. 14(5). e0215948–e0215948. 10 indexed citations

He, Xujun, et al.. (2019). The new role of riluzole in the treatment of pancreatic cancer through the apoptosis and autophagy pathways. Journal of Cellular Biochemistry. 122(9). 934–944. 12 indexed citations

Yang, Qiong, et al.. (2019). Thyroid Cancer Benefits the Prognosis of Ovarian Cancer: A SEER-Based Study. Advances in Therapy. 36(5). 1211–1220. 6 indexed citations

10.

Wang, Zhen, You‐Min Ying, Kaiqiang Li, et al.. (2017). Marsdeniae tenacissima extract-induced growth inhibition and apoptosis in hepatoma carcinoma cells is mediated through the p53/nuclear factor-κB signaling pathway. Experimental and Therapeutic Medicine. 14(3). 2477–2484. 3 indexed citations

11.

Zhang, Jun, Yongming Jin, Jiayin Zheng, et al.. (2016). AGR2 is associated with gastric cancer progression and poor survival. Oncology Letters. 11(3). 2075–2083. 32 indexed citations

12.

Li, Yaqing, Chao Gu, Jianping Yan, et al.. (2014). Therapeutic effects of amniotic fluid-derived mesenchymal stromal cells on lung injury in rats with emphysema. Respiratory Research. 15(1). 120–120. 29 indexed citations

13.

Tao, Hou‐Quan, Sheng Yu, Xujun He, et al.. (2014). Involvement of c-KIT mutation in the development of gastrointestinal stromal tumors through proliferation promotion and apoptosis inhibition. OncoTargets and Therapy. 7. 637–637. 13 indexed citations

14.

Wang, Yuanyu, Zai‐yuan Ye, Zhong‐Sheng Zhao, et al.. (2013). Clinicopathologic significance of miR-10b expression in gastric carcinoma. Human Pathology. 44(7). 1278–1285. 54 indexed citations

15.

He, Xujun, Xiaoting Jiang, Yingyu Ma, et al.. (2012). REG4 contributes to the invasiveness of pancreatic cancer by upregulating MMP‐7 and MMP‐9. Cancer Science. 103(12). 2082–2091. 35 indexed citations

16.

Zhang, Qi, Zai‐yuan Ye, Qiong Yang, et al.. (2012). Upregulated expression of Annexin II is a prognostic marker for patients with gastric cancer. World Journal of Surgical Oncology. 10(1). 103–103. 39 indexed citations

17.

Tao, Hou‐Quan, Xujun He, Ying‐Yu Ma, et al.. (2011). Evaluation of REG4 for early diagnosis and prognosis of gastric cancer. Human Pathology. 42(10). 1401–1409. 25 indexed citations

18.

Xia, Yingjie, Ying‐Yu Ma, Xujun He, et al.. (2011). Suppression of selenium-binding protein 1 in gastric cancer is associated with poor survival. Human Pathology. 42(11). 1620–1628. 28 indexed citations

19.

Zhang, Wei, Xujun He, Ying‐Yu Ma, et al.. (2011). Inducible nitric oxide synthase expression correlates with angiogenesis, lymphangiogenesis, and poor prognosis in gastric cancer patients. Human Pathology. 42(9). 1275–1282. 31 indexed citations

20.

He, Xujun, et al.. (2008). Haplotype sharing excludes orthologous COL4A3, COL4A4 or MYH9 loci in hereditary nephritis in bull terriers. Animal Genetics. 40(2). 252–253. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact